DermaSensor Receives $10 Million in Series B Financing

DermaSensor is a medical detection equipment developer, mainly engaged in the research and development of skin cancer detection equipment. The company developed a handheld device that can use the light-emitting tip to assess the possible presence of cancerous lesions on the patient’s skin surface. Recently announced the completion of a $10 million Series B financing, led by existing investors including Ceros Capital Markets. In addition to Maurice Ferre, other investors include Ernest Bachrach and Alberto Beeck.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.